ArticleJAC-antimicrobial resistance2026

Off-label use of oritavancin: a case series on clinical effectiveness, bed-day savings and cost benefits.

Amani Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.